New injection recommendations for patients with diabetesDAVIDSON, Jaime A.Diabetes & metabolism. 2010, Vol 36, issn 1262-3636, 29 p., NS2Serial Issue

Managing Chronic Kidney Disease in Type 2 Diabetes in Family PracticeSCOTT, David; DAVIDSON, Jaime A.Journal of the National Medical Association. 2011, Vol 103, Num 9-10, pp 952-959, issn 0027-9684, 8 p.Article

Is Hyperglycemia a Causal Factor in Cardiovascular Disease?: Does proving this relationship really matter? YesDAVIDSON, Jaime A; PARKIN, Christopher G.Diabetes care. 2009, Vol 32, Num 3, pp 5331-5333, issn 0149-5992, 3 p., SUPConference Paper

Strategies for improving glycemic control : effective use of glucose monitoringDAVIDSON, Jaime.The American journal of medicine. 2005, Vol 118, pp 27S-32S, issn 0002-9343, SUP9AConference Paper

The design and rationale of the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus-Thrombolysis in Myocardial Infarction (SAVOR-TIMI) 53 StudySCIRICA, Benjamin M; BHATT, Deepak L; RAZ, Itamar et al.The American heart journal. 2011, Vol 162, Num 5, pp 818-825, issn 0002-8703, 8 p.Article

Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes MellitusSCIRICA, Benjamin M; BHATT, Deepak L; CAVENDER, Matthew A et al.The New England journal of medicine. 2013, Vol 369, Num 14, pp 1317-1326, issn 0028-4793, 10 p.Article

Comparison of Insulin aspart with buffered regular Insulin and Insulin lispro in continuous subcutaneous Insulin infusion: A randomized study in type 1 diabetesBODE, Bruce; WEINSTEIN, Richard; BELL, David et al.Diabetes care. 2002, Vol 25, Num 3, pp 439-444, issn 0149-5992Article

Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized TrialSCIRICA, Benjamin M; BRAUNWALD, Eugene; POLLACK, Pia S et al.Circulation (New York, N.Y.). 2014, Vol 130, Num 18, pp 1579-1588, issn 0009-7322, 10 p.Article

A Retrospective Analysis of the Fasting Plasma Glucose and Glycosylated Hemoglobin and Pharmacotherapy Change Patterns Among Type 2 Diabetes Mellitus PatientsDAVIDSON, Jaime; KORO, Carol; ARONDEKAR, Bhakti et al.Clinical therapeutics. 2008, Vol 30, Num 2, pp 287-293, issn 0149-2918, 7 p.Article

Hypoglycemia in diabetes. CommentariesCRYER, Philip E; DAVIS, Stephen N; GOHDES, Dorothy et al.Diabetes care. 2003, Vol 26, Num 6, pp 1902-1921, issn 0149-5992, 20 p.Article

Statin and Aspirin Therapy for the Prevention of Cardiovascular Events in Patients With Type ₂ Diabetes MellitusUDELL, Jacob A; SCIRICA, Benjamin M; BRAUNWALD, Eugene et al.Clinical cardiology (Mahwah, NJ). 2012, Vol 35, Num 12, pp 722-729, issn 0160-9289, 8 p.Article

Biphasic insulin aspart 30 : Literature review of adverse events associated with treatmentDAVIDSON, Jaime; VEXIAU, Patrick; CUCINOTTA, Domenico et al.Clinical therapeutics. 2005, Vol 27, pp S75-S88, issn 0149-2918, SUPBArticle

A New-Generation Ultra-Long-Acting Basal Insulin With a Bolus Boost Conepared With Insulin Glargine in Insulin-Naive People With Type 2 Diabetes: A randomized, controlled trialHEISE, Tim; TACK, Cees J; CUDDIHY, Robert et al.Diabetes care. 2011, Vol 34, Num 3, pp 669-674, issn 0149-5992, 6 p.Article

Pioglitazone Use in Combination with Insulin in the Prospective Pioglitazone Clinical Trial in Macrovascular Events Study (PROactive19)CHARBONNEL, Bernard; DEFRONZO, Ralph; DAVIDSON, Jaime et al.The Journal of clinical endocrinology and metabolism. 2010, Vol 95, Num 5, pp 2163-2171, issn 0021-972X, 9 p.Article

Guidelines for the treatment and management of new-onset diabetes after transplantationWILKINSON, Alan; DAVIDSON, Jaime; NAICKER, Sarala et al.Clinical transplantation. 2005, Vol 19, Num 3, pp 291-298, issn 0902-0063, 8 p.Article

New-onset diabetes after transplantation 2003 International Consensus Guidelines: An endocrinologist's viewDAVIDSON, Jaime A; WILKINSON, Alan.Diabetes care. 2004, Vol 27, Num 3, pp 805-812, issn 0149-5992, 8 p.Article

Tolerability profile of metformin/glibenclamide combination tablets (glucovance®). A new treatment for the management of type 2 diabetes mellitusDAVIDSON, Jaime A; SCHEEN, André J; HOWLETT, Harry C. S et al.Drug safety. 2004, Vol 27, Num 15, pp 1205-1216, issn 0114-5916, 12 p.Article

Cardiovascular Disease in Diabetes Mellitus Risk Factors and Medical TherapySZUSZKIEWICZ-GARCIA, Magdalene M; DAVIDSON, Jaime A.Endocrinology and metabolism clinics of North America (Print). 2014, Vol 43, Num 1, issn 0889-8529, 25-40, vii [17 p.]Article

A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of the efficacy and tolerability of combination therapy with rosiglitazone and sulfonylurea in african american and hispanic american patients with type 2 diabetes inadequately controlled with sulfonylurea monotherapyDAVIDSON, Jaime A; MCMORN, Stephen O; WATERHOUSE, Brian R et al.Clinical therapeutics. 2007, Vol 29, Num 9, pp 1900-1914, issn 0149-2918, 15 p.Article

Risk for Nocturnal Hypoglycemia With Biphasic Insulin Aspart 30 Compared With Biphasic Human Insulin 30 in Adults With Type 2 Diabetes Mellitus: A Meta-AnalysisDAVIDSON, Jaime A; LIEBL, Andreas; CHRISTIANSEN, Jens S et al.Clinical therapeutics. 2009, Vol 31, Num 8, pp 1641-1651, issn 0149-2918, 11 p.Conference Paper

The Third Injection Technique Workshop In Athens (TITAN)FRID, A; HIRSCH, L; GASPAR, R et al.Diabetes & metabolism. 2010, Vol 36, issn 1262-3636, S19-S29, NS2Article

Muraglitazar, a dual (α/γ) PPAR activator : A randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetesBUSE, John B; RUBIN, Cindy J; FREDERICH, Robert et al.Clinical therapeutics. 2005, Vol 27, Num 8, pp 1181-1195, issn 0149-2918, 15 p.Article

Postprandial glucose regulation : New data and new implicationsLEITER, Lawrence A; CERIELLO, Antonio; DAVIDSON, Jaime A et al.Clinical therapeutics. 2005, Vol 27, pp S42-S56, issn 0149-2918, SUPBArticle